WealthCare Investment Partners’s Amgen AMGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$275K Sell
777
-5
-0.6% -$1.78K 0.08% 161
2025
Q4
$256K Sell
782
-10
-1% -$3.17K 0.07% 161
2025
Q3
$236K Buy
792
+7
+0.9% +$2.03K 0.08% 157
2025
Q2
$234K Buy
785
+6
+0.8% +$1.7K 0.08% 143
2025
Q1
$213K Hold
779
0.09% 140
2024
Q4
$202K Buy
779
+6
+0.8% +$1.78K 0.09% 143
2024
Q3
$245K Sell
773
-143
-16% -$46.8K 0.11% 123
2024
Q2
$286K Buy
+916
New +$269K 0.13% 109

Other funds holding AMGN

WealthCare Investment Partners's AMGN Position: Q1 2026 in Review

WealthCare Investment Partners reduced its Amgen (AMGN) stake by 0.64% in Q1 2026, selling an estimated $1.78K and leaving 777 shares worth $275K. The position accounts for 0.08% of the portfolio, ranked #161.

WealthCare Investment Partners first reported a position in AMGN in Q2 2024 and has held it in 8 quarters since. The position peaked at $286K in Q2 2024. 3,131 funds tracked by Wall St. Rank hold AMGN as of Q1 2026.

  • WealthCare Investment Partners held 777 shares of Amgen worth $275K as of Q1 2026.
  • WealthCare Investment Partners sold 5 Amgen shares in Q1 2026, an estimated $1.78K.
  • Amgen made up 0.08% of WealthCare Investment Partners's portfolio in Q1 2026, its #161 holding.
  • WealthCare Investment Partners first reported a position in Amgen in Q2 2024 and has held it in 8 quarters since.
  • WealthCare Investment Partners's Amgen position peaked at $286K in Q2 2024.
  • 3,131 funds tracked by Wall St. Rank held Amgen as of Q1 2026.

Based on WealthCare Investment Partners's 13F filing for Q1 2026, filed 9 Apr 2026.